Ion channel regulator (modulates chloride current, but is not itself an ion channel subunit; now recognized as a self-cleaving metalloprotease which regulates calcium-activated chloride conductance), Metalloprotease (zinc-dependent), Type I transmembrane protein
01
Overview
Calcium-activated chloride channel regulator 2 (CLCA2) is a type I transmembrane protein and member of the CLCA family, widely recognized as a regulator rather than a subunit of calcium-activated chloride channels. It possesses a self-cleaving zinc metalloprotease domain and modulates calcium-dependent chloride currents principally via interaction with signaling proteins STIM-1, ORAI-1, and indirectly TMEM16A. CLCA2 plays a critical role in epithelial cell physiology, including cell adhesion, differentiation, and apoptosis, and acts as a tumor suppressor, with markedly reduced expression in a range of adenocarcinomas and cervical carcinoma. It is induced by cellular stress and is essential for proper calcium signaling and chloride channel function in epithelia, and loss of CLCA2 is associated with increased metastatic and proliferative capacity in tumor cells.
Other names
Calcium-activated chloride channel regulator 2, 109 kDa formCalcium-activated chloride channel regulator 2, 35 kDa formCACC3hCLCA2CaCC-3CLCRG2Calcium-activated chloride channel family member 2Calcium-activated chloride channel protein 3CACCchloride channel regulatorcalcium-activated chloride channel protein 3CLCA family member 2chloride channel, calcium activated, family member 2
02
Mechanism of action
For investigational approaches: Tumor suppression via inhibition of EMT and cancer cell proliferation, through modulation of the p38/JNK/ERK pathway and calcium signaling. Modulation of intracellular calcium levels and chloride current indirectly by interaction with STIM-1 and ORAI-1 and enhancement of TMEM16A activity.
03
Biological functions
Regulation of calcium-activated chloride channels (notably TMEM16A/ANO1)Regulation of store-operated calcium entry (SOCE) through interaction with STIM-1 and ORAI-1Modulation of cell adhesion and stratification of squamous epitheliaInhibition of epithelial-mesenchymal transition (EMT)Induction by p53 in response to cellular stress (cell detachment, DNA damage)Role in epithelial differentiation and apoptosis
04
Disease associations
Tumor suppressor in several cancers, especially breast, prostate, colorectal and cervical cancersDownregulated in various carcinomas (notably breast, cervical, prostate)Involved in cystic fibrosis pathogenesisAssociated with inflammatory bowel disease, familial cardiac disease, chronic lymphocytic leukemia
05
Safety considerations
No specific safety concerns reported for direct therapeutic targeting (no drugs currently approved). Challenges: tissue-specific effects and potential unintended modulation of chloride and calcium homeostasis or differentiation in non-cancerous epithelia if targeted therapeutically
06
Interacting drugs
None currently established as clinically approved direct drugs targeting CLCA2. It is a research target; overexpression or silencing is being explored in preclinical models for possible modulation of cancer progression
07
Biomarkers
Loss or reduced expression (downregulation by promoter methylation) of CLCA2 is a biomarker for poor prognosis in breast and cervical cancerPotential diagnostic and prognostic biomarker in various epithelial cancers due to its tumor suppressor role and decreased expression in malignancy
Beyond the preview
Go deeper on Calcium-activated chloride channel regulator 2 (CLCA2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calcium-activated chloride channel regulator 2 (CLCA2).